Conroy Wong
Overview
Explore the profile of Conroy Wong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
868
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bryce A, Foley L, Phillipson J, Slow S, Storer M, Williman J, et al.
N Z Med J
. 2022 Jun;
135:120-130.
PMID: 35728191
Aim: As New Zealand transitions towards endemic SARS-CoV-2, understanding patient factors predicting severity, as well as hospital resourcing requirements will be essential for future planning. Methods: We retrospectively enrolled patients...
12.
Herath S, Wong C, Dawkins P, Veale A, Yap E, Williamson J, et al.
Intern Med J
. 2022 Jun;
53(8):1390-1399.
PMID: 35675149
Background: Computed tomography-guided transthoracic biopsy (CT-TTB) is the 'gold standard' biopsy for lung nodules. Radial-endobronchial ultrasound (R-EBUS) bronchoscopy is another recommended biopsy but carries a lower diagnostic yield. Addition of...
13.
Jayaram L, Vandal A, Chang C, Lewis C, Tong C, Tuffery C, et al.
Eur Respir J
. 2021 Nov;
59(6).
PMID: 34795034
Background: Tiotropium the HandiHaler device is an established long-acting, anticholinergic bronchodilator that prevents exacerbations and improves lung function in patients with chronic obstructive pulmonary disease. We hypothesised that tiotropium would...
14.
Good W, Jeon G, Zeng I, Storey L, Qiao H, Jones S, et al.
ERJ Open Res
. 2021 Oct;
7(4).
PMID: 34708111
Sputum procalcitonin is elevated in exacerbations of bronchiectasis. The primary aim of this study was to investigate whether sputum procalcitonin levels are higher in patients with stable bronchiectasis than in...
15.
Popowicz N, Piccolo F, Yap E, Wong C, Brockway B, Smith N, et al.
Respirology
. 2021 Feb;
26(4):388-391.
PMID: 33590570
No abstract available.
16.
Good W, Garrett J, Hockey H, Jayaram L, Wong C, Rea H
ERJ Open Res
. 2021 Feb;
7(1).
PMID: 33585655
https://bit.ly/2JFXuQc.
17.
Huang Q, Wood T, Jelley L, Jennings T, Jefferies S, Daniells K, et al.
Nat Commun
. 2021 Feb;
12(1):1001.
PMID: 33579926
Stringent nonpharmaceutical interventions (NPIs) such as lockdowns and border closures are not currently recommended for pandemic influenza control. New Zealand used these NPIs to eliminate coronavirus disease 2019 during its...
18.
Good W, Mooney S, Zeng I, Taylor S, Jayaram L, Holland D, et al.
Health Sci Rep
. 2020 Dec;
3(4):e203.
PMID: 33313422
No abstract available.
19.
Huang Q, Wood T, Jelley L, Jennings T, Jefferies S, Daniells K, et al.
medRxiv
. 2020 Nov;
PMID: 33200149
Stringent nonpharmaceutical interventions (NPIs) such as lockdowns and border closures are not currently recommended for pandemic influenza control. New Zealand used these NPIs to eliminate coronavirus disease 2019 during its...
20.
Tautolo E, Wong C, Vandal A, Jalili-Moghaddam S, Griffiths E, Iusitini L, et al.
JMIR Res Protoc
. 2020 Oct;
9(10):e18916.
PMID: 33084587
Background: Respiratory disease is the third most common cause of death in New Zealand, with Pacific people living in New Zealand bearing the greatest burden of this type of disease....